文献速递淋巴瘤

侵袭性非霍奇金淋巴瘤基因组图谱的临床应用

Clinical Applications of the Genomic Landscape of Aggressive Non-Hodgkin Lymphoma.
PubMed 文献 · J Clin Oncol · 2017-02-13

本综述检视了起源于B细胞、T细胞和自然杀伤细胞的淋巴瘤的基因组图谱,涵盖伯基特淋巴瘤、弥漫大B细胞淋巴瘤、霍奇金淋巴瘤、原发纵隔B细胞淋巴瘤及多种T细胞淋巴瘤。文章描述了微阵列和第二代测序等基因组技术所揭示的分子基础,并讨论了基于这些发现的新治疗机会。

要点

  • 综述涵盖B细胞、T细胞和NK细胞来源的淋巴瘤的基因组图谱。
  • 微阵列和第二代测序增进了对这些肿瘤分子基础的理解。
  • 文章讨论了基因组发现带来的新治疗机会。

核心结论

  • 基因组技术增进了对侵袭性非霍奇金淋巴瘤分子基础的理解,并带来新的治疗机会。

研究设计与样本

  • 综述,检视起源于B细胞、T细胞和自然杀伤细胞的淋巴瘤的基因组图谱。

主要发现

  • 所涵盖的B细胞淋巴瘤包括伯基特淋巴瘤、弥漫大B细胞淋巴瘤、霍奇金淋巴瘤和原发纵隔B细胞淋巴瘤。
  • 所涵盖的T细胞淋巴瘤包括间变性大细胞淋巴瘤、血管免疫母细胞性T细胞淋巴瘤、皮肤T细胞淋巴瘤、成人T细胞白血病/淋巴瘤及其他外周T细胞淋巴瘤。
  • 微阵列和第二代测序等基因组技术增进了对这些癌症分子基础的理解。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In this review, we examine the genomic landscapes of lymphomas that arise from B, T, and natural killer cells. Lymphomas represent a striking spectrum of clinical behaviors. Although some lymphomas are curable with standard therapy, the majority of the affected patients succumb to their disease. Here, the genetic underpinnings of these heterogeneous entities are reviewed. We consider B-cell lymphomas, including Burkitt lymphoma, diffuse large B-cell lymphoma, Hodgkin lymphoma, and primary mediastinal B-cell lymphoma. We also examine T-cell lymphomas, including anaplastic large-cell lymphoma, angioimmunoblastic T-cell lymphoma, cutaneous T-cell lymphoma, adult T-cell leukemia/lymphoma, and other peripheral T-cell lymphomas. Together, these malignancies make up most lymphomas diagnosed around the world. Genomic technologies, including microarrays and next-generation sequencing, have enabled a better understanding of the molecular underpinnings of these cancers. We describe the broad genomics findings that characterize these lymphoma types and discuss new therapeutic opportunities that arise from these findings.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Moffitt AB, Dave SS. Clinical Applications of the Genomic Landscape of Aggressive Non-Hodgkin Lymphoma. J Clin Oncol. 2017. PMID: 28297626. doi:10.1200/JCO.2016.71.7603

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。